Flow cytometric analysis of human PBMC (human peripheral blood mononuclear cells) labelling Human CD304 antibody at 1/200 (1 μg) dilution/ (Right panel) compared with a Mouse IgG1, κ Isotype Control / (Left panel). Goat Anti-Mouse IgG Alexa Fluor® 488 was used as the secondary antibody. Then cells were stained with CD123 - PE/Cy7 Antibody separately.
Product Details
Product Details
Product Specification
Host | Mouse |
Antigen | CD304 |
Synonyms | Neuropilin-1; Vascular endothelial cell growth factor 165 receptor; NRP; VEGF165R; NRP1 |
Location | Cytoplasm, Mitochondrion, Cell membrane |
Accession | O14786 |
Clone Number | S-R695 |
Antibody Type | Mouse mAb |
Isotype | IgG2a,k |
Application | FCM |
Reactivity | Hu |
Purification | Protein A |
Concentration | 2 mg/ml |
Conjugation | Unconjugated |
Physical Appearance | Liquid |
Storage Buffer | PBS pH7.4 |
Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied. |
Dilution
application | dilution | species |
FCM | 1:200 | Hu |
Background
CD304, also known as Neuropilin-1 (NRP-1) or BDCA-4, is a type I transmembrane glycoprotein that plays crucial roles in various biological processes. It was initially discovered on the cell membrane of plasmacytoid dendritic cells (pDCs) and is also expressed on thymocytes, regulatory T cells (Tregs), and endothelial cells. CD304 is involved in neuronal development, angiogenesis, and immunosuppression by interacting with plexins and VEGF receptors. In the field of hematology, CD304 is particularly useful as a marker for minimal residual disease detection in B-cell precursor acute lymphoblastic leukemia (BCP-ALL) and has been shown to be highly expressed in certain hematological malignancies such as blastic plasmacytoid dendritic cell neoplasm (BPDCN) and acute myeloid leukemia (AML). Additionally, CD304 is used to distinguish between different subsets of Tregs, which is important for understanding immune regulation.
Picture
Picture
FC
